Abstract
The observation that profound losses in neocortical cholinergic innervation (Davies and Maloney, 1976; Perry et al., 1978; Whitehouse et al., 1982; Coyle et al., 1983) occur in Alzheimer’s disease (AD) and data pointing to the importance of cholinergic function to learning and memory in animals (El-Defrawy et al, 1985; Watson et al. 1985, Hepler et al., 1985) have led to what has been called the cholinergic hypothesis of AD. This hypothesis states that the cholinergic losses observed in AD lead, at least in part, to the cognitive and mnemonic deficits observed in the disease. However, with the wide range of neurochemical alterations now documented in AD the cholinergic hypothesis appears to be an oversimplification (Price, 1986; D’Amato et al., 1987; Struble et al., 1987).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
M.G. Baxter, K.W. Rohrbach, S.W. Tam, R. Zaczek, K.M. Frick, S. Golski, R.-Q. Wan, and D.S. Olton, 1993, Effects of linopirdine (DuP 996) and X9121 on age-related memory impairments and on the cholinergic system, Drug Devel. Res.,in press.
J.D. Brion, P. Curzon, M.J. Buckley, S.P. Americ, and M.W. Decker, 1993, Linopirdine (DuP996) facilitates the retention of avoidance training and improves performance of septal-lesioned rats in the water maze, Pharmacol. Biochem. Behay. 44: 37–43.
L. Cook L, G.F. Steinfels, K.W. Rohrbach and V.J. DeNoble, 1990, Cognition enhancement by the acetylcholine releaser DuP 996, Drug Devel. Res. 19: 301–314.
J.T. Coyle, D. Price, and M. DeLong, 1983, Alzheimer’s Disease: a disorder of cholinergic innervation, Science 219: 1184–1190.
R.J. D’Amato, R.M. Zweig, P.J. Whitehouse, G.L. Wenk, H.S. Singer, R. Mayeux, D.L. Price, and S.H. Snyder, 1987, Aminergic systems in Alzheimer’s disease and Parkinson’s disease, Ann. Neurol. 22: 229–236.
P. Davies and A.J.F. Maloney, 1976, Selective loss of central cholinergic neurons in Alzheimer’s disease, Lancet 11: 1403.
R.E. Davis, M.E. Emmerling, J.C. Jaen, W.H. Moos, and K. Spiegel, 1993, Therapeutic intervention in dementia, Crit. Rev. Neurobiol. 7: 41–83.
E.B. De Souza, B.L. Rule, and S.W. Tam, 1992, [3H]Linopirdine (DuP 996) labels a novel binding site in rat brain involved in the enhancement of stimulus-induced neurotransmitter release: autoradiographic localization studies, Brain Res. 582: 335–341.
V.J. DeNoble, K.F. DeNoble, and K.R. Spencer, 1991, Protection against hypoxia-induced passive avoidance deficits: interactions between DuP 996 and ketanserin, Brain Res. Bull. 26: 817–20.
V.J. DeNoble, K.F. DeNoble, K.R. Spencer, L.C. Johnson, L. Cook, M.J. Myers, and R.M. Scribner, 1990, Comparison of DuP 996, with physostigmine, THA and 3,4-DAP on hypoxia-induced amnesia in rats, Pharmacol. Biochem. Behay. 36: 957–61.
G. Dent, S.W. Tam, and R. Grzanna, 1993, The memory enhancer linopirdine increases c-fos expression in cerebral cortex of aged rats, Soc. Neurosci. Abstr. 23: 4236.
S.R. El-Defrawy, F. Coloma, K. Jhamandas, R.J. Boegman, R.J. Beninger, and B.A. Wisching, 1985, Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat, Neurobiol. Aging 6: 325–330.
J.M. Frey, P.A. Murphy, and B.S. Brown, 1991, DuP 996, a novel neurotransmitter releaser, blocks voltage-activated potassium currents in cultured neocortical neurons, Soc. Neurosci. Abstr. 21: 63220.
D.J. Hepler, G.L. Wenk, B.L. Cribbs, D.S. Olton, and J.T. Coyle, 1985, Memory impairments following basal forebrain lesions, Brain Res. 346: 8–14.
B.W. Lampe and B.S. Brown, 1991, Electrophysiological effects of DuP 996 on hippocampal CAI neurons. Soc. Neurosci. Abstr. 21: 632. 19.
M. Marynowski, C. Maciag, C.M. Rominger, S.W. Tam, and R. Zaczek, 1993, Effects of linopirdine (DuP 996) on hippocampal extracellular levels of acetylcholine in freely moving animals, Soc. Neurosci. Abstr. 23: 4238.
V.J. Nickolson, S.W. Tam, M.J. Meyers, and L. Cook, 1990, DuP996 (3,3(4-pyrindylmethyl)lphenylindolin-2-one) enhances the stimulus evoked release of acetylcholine from rat brain in-vitro and in vivo, Drug Dev. Res. 19:285–300.
E.K. Perry, B.E. Tomlinson, G. Blessed, K. Bergman, P.H. Gibson, and R.H. Perry, 1978, Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, Br. Med. J. 2: 1427–1429.
D.L. Price, 1986, New perspectives on Alzheimer’s disease, Ann. Rev. Neurosci. 9: 489–512.
K.W. Rohrbach and L. Cook, 1990, An acquisition of lever pressing for food paradigm sensitive to the associative effects of drugs, The FASEB J. 4: A1109.
B. Saletu, A. Darragh, H.P. Breuel, W. Herrmann, P. Salmon, R. Coen, and P. Anderer, 1991, EEG mapping central effects of multiple doses of linopirine -a cognitive enhancer-in healthy elderly male subjects, Human Psychopharmacol. 6:267–275.
B. Saletu, A. Darragh, P. Salmon, and R. Coen, 1989, EEG brain mapping in evaluating the time-course of the central action of DUP 996-a new acetylcholine releasing drug, Br. J. Clin. Pharmacol. 28: 1–16.
J.A. Saydoff and R. Zaczek, 1993a, Linopirdine enhances KCI evoked release, but not basal release, of endogenous dopamine in superfused rat striatum, FASEB Abstr. 1521.
J.A. Saydoff and R. Zaczek, 19936, The role of Ca’ channels, adenosine, and Ca“ stores on KCl evoked acetylcholine release and linopirdine (DuP 996) release enhancement in rat hippocampal slices, Soc. Neurosci. Abstr. 23: 4239.
C.P. Smith, L.R. Broughm, and H.M. Vargus, 1993, Linopirdine (DuP 996) selectively enhances acetylcholine release induced by high potassium but not electrical stimulation in rat brain slices and guinea-pig ileum, Drug Devel. Res. 29: 262–270.
T.M. Smith, A.D. Ramirez, S.D. Heck, V.J. Jasys, R.A. Volkmann, J.T. Forman, and D.R. Liston, 1993, In vivo microdialysis and pharmacokinetic studies with DuP996, Soc. Neurosci. Abstr. 19: 4 2311.
R.G. Struble, R.E. Powers, M.F. Casanova, C.A. Kitt, E.C. Brown, and D.L. Price, 1987, Neuropeptidergic systems in plaques of Alzheimer’s Disease, J. Neuropathol. Exp. Neurol. 46: 567–584.
S.W. Tam, D. Rominger, and V.J. Nickolson, 1991, Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release, Mol. Pharmacol. 40: 16–21.
W.J. Tinker, C. Maciag, S.W. Tam, and R. Zaczek, 1992, Effects of linopirdine (DuP 996) on KCI and CaCl2 dose response of potassium evoked release of [3H] acetylcholine from superfused hippocampal slices, Soc. Neurosci. Abstr. 22: 5 1812.
T.W. Vickroy, 1993, Presynaptic cholinergic actions by the putative cognitive enhancing agent DuP 996. J. Pharmacol. Exp. Pier. 264: 910–7.
M. Watson, T.W. Vickroy, H.C. Fibiger, W.R. Roeske, and H.I. Yamamura, 1985, Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex, Brain Res. 346: 387–391.
P. Whitehouse, D. Price, R. Struble, A. Clark, J.T. Coyle, and M. DeLong, 1982, Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain, Science 215: 237–239.
R. Zaczek, C. Maciag, and W.J. Tinker, 1993, Effects of linopirdine (DuP 996) on the KCI, veratridine, NMDA and electrically induced release of [3H] acetylcholine from superfused brain slices, Soc. Neurosci. Abstr. 23: 423. 7.
R. Zaczek, W.J. Tinker, A.R. Logue, G.A. Cain, C.A. Teleha, and S.W. Tam, 1993a, Effects of linopirdine, HP-749, and Glycyl-Prolyl-Glutamate on transmitter release and uptake, Drug Develop. Res. 29: 203–208.
R. Zaczek, W.J. Tinker, and S.W. Tam, 1993b, Unique properties of norepinephrine release from terminals arising from the locus coeruleus: high potassium sensitivity and lack of linopirdine (DuP 996) enhancement, Neurosci. Lett. 155: 107–111.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zaczek, R., Rohrbach, K.W., Tam, S.W., Cook, L. (1995). Preclinical Evaluation of Linopirdine: Neurochemical and Behavioral Effects. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_72
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_72
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive